Financials

  • Market Capitalization 137.68 M
  • Employee 57
  • Founded 2014
  • CEO N/A
  • Website www.korrobio.com
  • Headquarter Delaware, United States
  • FIGI BBG00GFMTC38
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.64
Rapporto prezzo/fatturato
11.77

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3695
CDXS
Codexis, Inc. - Common Stock
1.41 USD0.00%+1.44%-2.76%-46.39%154.40 M USD
3696
ABOS
Acumen Pharmaceuticals, Inc. - Common Stock
2.02 USD-5.61%-5.16%-30.58%-5.61%146.08 M USD
3706
AVXL
Anavex Life Sciences Corp. - Common Stock
1.52 USD+2.01%-7.88%-41.76%-83.64%140.90 M USD
3708
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.58 USD-3.33%-1.69%-10.77%+40.61%141.20 M USD

Notizie